Literature DB >> 10334393

Direct comparison of the effects of CSF-1 (M-CSF) and GM-CSF on human monocyte DNA synthesis and CSF receptor expression.

M Finnin1, J A Hamilton, S T Moss.   

Abstract

There is evidence that a proportion of human monocytes can proliferate in vitro in response to colony-stimulating factor-1 (CSF-1, also known as M-CSF) and granulocyte-macrophage CSF (GM-CSF). To determine whether there are differences in DNA synthesis responses to these CSF, a large study using purified human peripheral blood monocytes from 45 donors was performed under optimized culture conditions. In contrast to the consistent response to CSF-1, approximately 20% of donors have monocytes that do not respond or have a minimal DNA synthesis response to GM-CSF stimulation. However, analysis demonstrated that no statistically significant differences exist in the levels of CSF-1 and GM-CSF-stimulated proliferation in monocytes. In addition, CSF-1 receptor (CSF-1R) blocking experiments indicated that a proportion of the GM-CSF-induced DNA synthesis is due to endogenous levels of CSF-1. As a further comparison of the actions of the two CSFs, CSF-1R and GM-CSFR levels were measured by flow cytometry, and it was shown that GM-CSFR levels decreased within 5 days of culture, independent of the conditions examined. In contrast, CSF-1R levels at day 5 approximated those measured in uncultured monocytes. Whether the proliferating subpopulation(s) express one or both CSF receptors at the beginning or at the end of culture is as yet unknown. The information obtained in this study will be useful for the design of strategies to enrich for the subpopulation in question based on CSF receptor expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334393     DOI: 10.1089/107999099314126

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness.

Authors:  M Maximina Bertha Moreno-Altamirano; Israel Aguilar-Carmona; F Javier Sánchez-García
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

2.  [Prostate cancer screening with a new marker based on circulating blood macrophages?].

Authors:  R Herwig; B Djavan; G Kramer; M A El-Taieb; F Kühhas; M Leers; M Marberger
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

3.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

Authors:  James G Conway; Brad McDonald; Janet Parham; Barry Keith; David W Rusnak; Eva Shaw; Marilyn Jansen; Peiyuan Lin; Alan Payne; Renae M Crosby; Jennifer H Johnson; Lloyd Frick; Min-Hwa Jasmine Lin; Scott Depee; Sarva Tadepalli; Bart Votta; Ian James; Karen Fuller; Timothy J Chambers; Frederick C Kull; Stanley D Chamberlain; Jeff T Hutchins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

4.  Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels.

Authors:  Maja Klug; Sven Heinz; Claudia Gebhard; Lucia Schwarzfischer; Stefan W Krause; Reinhard Andreesen; Michael Rehli
Journal:  Genome Biol       Date:  2010-06-18       Impact factor: 13.583

5.  Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

Authors:  David J Mock; Joseph A Hollenbaugh; Waaqo Daddacha; Michael G Overstreet; Chris A Lazarski; Deborah J Fowell; Baek Kim
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

6.  The proliferative human monocyte subpopulation contains osteoclast precursors.

Authors:  Roya Lari; Peter D Kitchener; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2009-02-17       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.